Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Breast implant settlement

This article was originally published in The Gray Sheet

Executive Summary

Dow Corning signs "a written agreement specifying the terms for its participation in a proposed global settlement for silicone breast implant litigation," pending board approval, the firm announces March 23. Bristol-Myers Squibb and Baxter also have signed onto the deal. Terms of the agreement are said to be substantially the same as those proposed in February ("The Gray Sheet" Feb. 21, p. 12). 3M is still in negotiations. Court review of the agreement should occur in the "very near future," Baxter says
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002056

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel